Source - SMW
JP Morgan Cazenove today reaffirms its overweight investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and cut its price target to 140p (from 170p).

Related Charts

Circassia Pharmaceuticals (CIR)

+2.50p (+2.84%)
delayed 18:15PM